Renaissance Technologies - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 26 filers reported holding REGULUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$69
+1.5%
50,100
+8.7%
0.00%
Q2 2023$68
+106.1%
46,100
+18.8%
0.00%
Q1 2023$33
-31.2%
38,800
+11.5%
0.00%
Q4 2022$48
-99.9%
34,800
+7.4%
0.00%
Q3 2022$55,000
-5.2%
32,400
+15.3%
0.00%
Q2 2022$58,00028,1000.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 555,555$1,150,0000.31%
Ikarian Capital, LLC 105,341$217,0000.04%
Sarissa Capital Management LP 185,183$383,0000.04%
FEDERATED HERMES, INC. 2,904,826$6,013,0000.02%
Virtu Financial LLC 10,205$21,0000.00%
VICTORY CAPITAL MANAGEMENT INC 221,506$459,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 11,583$24,0000.00%
VANGUARD GROUP INC 372,732$772,0000.00%
UBS Group AG 8,252$17,0000.00%
Community Bank, N.A. 690$1,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders